- About
- Projects
- Column 1
- Animal Health & Veterinary Medicine
- Expanded Access
- FDA Patient Listening Sessions
- Food & Nutrition
- Column 2
- Column 1
- News and Events
- Expanded Access eRequest
TransCelerate BioPharma Inc.: TransCelerate BioPharma to Highlight Collaboration, Innovation, and Patient-Centric Research at DIA 2025
TransCelerate BioPharma (TransCelerate), a nonprofit organization dedicated to improving the health of people around the world by accelerating and simplifying the clinical research process, today announced its participation in numerous sessions at the DIA 2025 Global Annual Meeting in Washington, D.C. from June 15–19.
NC Political News: OpEd: FDA’s Center for Tobacco Products Needs Serious Reforms
In fact, according to a report by the independent Reagan-Udall Foundation, the CTP under the previous administration suffered from ineffective leadership, a lack of direction and a culture that stifles scientific integrity.
King & Spalding: Administrative, Congressional, and State Interest Signal a Potential Breakthrough Moment for Psychedelics
In 2024, a workshop cohosted by FDA and the Reagan-Udall Foundation for the FDA (Reagan-Udall) focusing on advancing psychedelic clinical study design. Also in 2024, a second workshop by Reagan-Udall focusing specifically on understanding potential therapeutic uses of ketamine.
FDA's Final Rule on Requirements for Additional Traceability Records for Certain Foods
The Reagan-Udall Foundation for the FDA, in cooperation with the Food and Drug Administration, hosted a Food Traceability Rule public webinar featuring experts from various sectors of the food industry and FDA.